330 related articles for article (PubMed ID: 19696704)
21. Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate.
Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
J Clin Pharmacol; 2007 Mar; 47(3):343-50. PubMed ID: 17322146
[TBL] [Abstract][Full Text] [Related]
22. The analgesic effect of paracetamol when added to lidocaine for intravenous regional anesthesia.
Sen H; Kulahci Y; Bicerer E; Ozkan S; Dagli G; Turan A
Anesth Analg; 2009 Oct; 109(4):1327-30. PubMed ID: 19762765
[TBL] [Abstract][Full Text] [Related]
23. Patient-controlled analgesia with fentanyl for burn dressing changes.
Prakash S; Fatima T; Pawar M
Anesth Analg; 2004 Aug; 99(2):552-5, table of contents. PubMed ID: 15271737
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of oral paracetamol and ketoprofen for pain management after major orthopedic surgery.
Karvonen S; Salomäki T; Olkkola KT
Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):703-6. PubMed ID: 19229379
[TBL] [Abstract][Full Text] [Related]
25. Danish pain specialists' rationales behind the choice of fentanyl transdermal patches and oral transmucosal systems--a delphi study.
Jacobsen R; Møldrup C; Christrup L
Pain Med; 2009 Nov; 10(8):1442-51. PubMed ID: 19793344
[TBL] [Abstract][Full Text] [Related]
26. Oral transmucosal fentanyl citrate versus placebo for painful dressing changes: a crossover trial.
MacIntyre PA; Margetts L; Larsen D; Barker L
J Wound Care; 2007 Mar; 16(3):118-21. PubMed ID: 17385588
[TBL] [Abstract][Full Text] [Related]
27. Effect of laser spot diameter on the reproducibility of visual field analysis in diabetic patients with upper temporal retinal vein occlusion.
Akar Y; Apaydin KC; Metinsoy M
Ophthalmologica; 2008; 222(2):64-8. PubMed ID: 18303224
[TBL] [Abstract][Full Text] [Related]
28. [Does combination of intrathecal magnesium sulfate and morphine improve postcaesarean section analgesia?].
Ghrab BE; Maatoug M; Kallel N; Khemakhem K; Chaari M; Kolsi K; Karoui A
Ann Fr Anesth Reanim; 2009 May; 28(5):454-9. PubMed ID: 19427159
[TBL] [Abstract][Full Text] [Related]
29. Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ).
Taylor DR; Webster LR; Chun SY; Reinking J; Stegman M; Shoemaker S; Fortner B
Pain Med; 2007 Apr; 8(3):281-8. PubMed ID: 17371416
[TBL] [Abstract][Full Text] [Related]
30. [Oral transmucosal fentanyl citrate (OTFC) in the treatment of breakthrough pain].
Borgbjerg FM; Rosenberg J
Ugeskr Laeger; 2000 Sep; 162(39):5237-40. PubMed ID: 11043058
[TBL] [Abstract][Full Text] [Related]
31. Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.
Koltzenburg M; Pokorny R; Gasser UE; Richarz U
Pain; 2006 Dec; 126(1-3):165-74. PubMed ID: 16901645
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
Foster D; Upton R; Christrup L; Popper L
Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
[TBL] [Abstract][Full Text] [Related]
33. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients.
Farrar JT; Cleary J; Rauck R; Busch M; Nordbrock E
J Natl Cancer Inst; 1998 Apr; 90(8):611-6. PubMed ID: 9554444
[TBL] [Abstract][Full Text] [Related]
34. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).
Coluzzi PH; Schwartzberg L; Conroy JD; Charapata S; Gay M; Busch MA; Chavez J; Ashley J; Lebo D; McCracken M; Portenoy RK
Pain; 2001 Mar; 91(1-2):123-30. PubMed ID: 11240084
[TBL] [Abstract][Full Text] [Related]
35. Epidural sufentanil provides better analgesia from 24 h after surgery compared with epidural fentanyl in children.
Cho JE; Kim JY; Kim JE; Chun DH; Jun NH; Kil HK
Acta Anaesthesiol Scand; 2008 Nov; 52(10):1360-3. PubMed ID: 19025528
[TBL] [Abstract][Full Text] [Related]
36. Factors in the choice of oral transmucosal fentanyl citrate dose for adult burns dressings.
Shah H; Smythe J; Hanafiah Z; Williams GJ; Holdcroft A
Burns; 2009 Sep; 35(6):798-801. PubMed ID: 19167829
[TBL] [Abstract][Full Text] [Related]
37. Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis.
Shaiova L; Lapin J; Manco LS; Shasha D; Hu K; Harrison L; Portenoy RK
Support Care Cancer; 2004 Apr; 12(4):268-73. PubMed ID: 14750002
[TBL] [Abstract][Full Text] [Related]
38. Capsicum plaster at the Hegu point reduces postoperative analgesic requirement after orthognathic surgery.
Kim KS; Kim KN; Hwang KG; Park CJ
Anesth Analg; 2009 Mar; 108(3):992-6. PubMed ID: 19224815
[TBL] [Abstract][Full Text] [Related]
39. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.
Christie JM; Simmonds M; Patt R; Coluzzi P; Busch MA; Nordbrock E; Portenoy RK
J Clin Oncol; 1998 Oct; 16(10):3238-45. PubMed ID: 9779697
[TBL] [Abstract][Full Text] [Related]
40. Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain.
Mercadante S; Villari P; Ferrera P; Casuccio A; Mangione S; Intravaia G
Br J Cancer; 2007 Jun; 96(12):1828-33. PubMed ID: 17519902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
